Skip to content

Total Revenue at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.99B+7.8%
Arrowhead Research logo
Arrowhead ResearchARWR
$73.74M-86.4%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$1.46M+68.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$272.55M-76.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$194.52M+66.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$56.37M+99.0%

Other financials

Income statement

See full
Operating income-$107.2M+10.1%
Net income-$94.3M+12.9%
EPS (diluted)-$0.91+26.0%

Balance sheet

See full
Cash & equivalents$288.3M-45.4%
Total debt$250.8M+58.6%
Total equity$1.2B+3.1%
Total assets$1.5B+0.9%

Cash flow

See full
Operating cash flow-$128.5M-23.7%
CapEx$2.2M-27.2%
Free cash flow-$130.7M-22.2%

Valuation

See full
Market cap$3.51B+24.5%
Enterprise value$3.47B+51.2%
P/S21.4×-23.0×

Profitability

See full
Operating margin-226.6%-90.5pp
Net margin-742.7%
FCF margin-234%-86.6pp

Returns & leverage

See full
Return on equity-47.1%
Debt / equity0.2×+0.1×
Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beam Therapeutics's total revenue?
Beam Therapeutics (BEAM) reported total revenue of $31.74M in Q1 2026.
How has Beam Therapeutics's total revenue changed year-over-year?
Beam Therapeutics's total revenue increased by 324.9% year-over-year, from $7.47M to $31.74M.
What is the long-term trend for Beam Therapeutics's total revenue?
Over 4 years (2021 to 2025), Beam Therapeutics's total revenue has grown at a 28.1% compound annual growth rate (CAGR), from $51.84M to $139.74M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.